MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
45.99
-1.13 (-2.40%)
Jan 31, 2025, 4:00 PM EST - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $2.90 billion as of January 31, 2025. Its market cap has decreased by -14.22% in one year.
Market Cap
2.90B
Enterprise Value
2.41B
1-Year Change
-14.22%
Ranking
Category
Stock Price
$45.99
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $2.90B, an increase of 80,507.18%. That is a compound annual growth rate of 855.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 2.90B | -15.07% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |